SCHEMBL4760593

SCHEMBL4760593

CC(CO)NC(=O)Oc1[nH]c2ccc(S(=O)(=O)Nc3ccc(C(C)(C)C)cc3)cc2c1-c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
SERPINE1 P05121 1/20 0.43
PDE3A Q14432 1/20 0.42
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
PKM P14618 1/20 0.39
CA12 O43570 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
PTPN5 P54829 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
TP53 P04637 2/20 0.38
USP2 O75604 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3944734 0.95 BRD4 (0.50) BRD4SERPINE1CA1CA2PTPN5
SCHEMBL3944739 0.87 BRD4 (0.49) BRD4SERPINE1CA1CA2PTPN5
SCHEMBL3951354 0.87 BRD4 (0.49) BRD4SERPINE1CA1CA2PTPN5
SCHEMBL3952994 0.87 BRD4 (0.49) BRD4SERPINE1CA1CA2PTPN5
SCHEMBL4761303 0.87 SERPINE1 (0.46) BRD4SERPINE1PDE3ACA1CA2
SCHEMBL4762480 0.86 BRD4 (0.51) BRD4SERPINE1PDE3ACA1CA2
SCHEMBL5149516 0.86 CA1 (0.49) BRD4SERPINE1PDE3ACA1CA2
SCHEMBL3945870 0.86 BRD4 (0.49) BRD4SERPINE1PTPN5HSP90AA1HSP90AB1
SCHEMBL4762525 0.84 CA1 (0.36) CA1CA2CA12CA4CA6
SCHEMBL4762731 0.83 BRD4 (0.46) BRD4SERPINE1PDE3ACA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001843-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP claimed
WO-2007107384-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-09-27 WO claimed
EP-2001843-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2008-12-17 EP disclosed
WO-2007107384-A2 SOLUBLE ADENYLATE CYCLASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-09-27 WO disclosed